XML 24 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities:      
Net earnings (loss) $ 264 $ (382) $ 282
Loss (gain) from discontinued operations   3 (113)
Non-cash charges (credits):      
Depreciation 369 390 388
Amortization of intangibles and other deferred items 99 109 106
Amortization of finance fees and debt discount 14 10 13
Deferred tax provision (benefit) (5) 7 (9)
Pension expense 38 32 32
Restructuring, asset impairment and related charges 96 69 92
Charges for asbestos-related cost   35 125
Pension settlement charges 26 26 74
Goodwill impairment charge   595  
Gain on sale of equity investment   (107)  
Gain on sale of ANZ business (275)    
Other asset impairments 36 22  
Pension contributions (103) (33) (34)
Asbestos-related payments   (151) (105)
Cash paid for restructuring activities (37) (54) (32)
Change in components of working capital (181) (176) 15
Other, net 116 13 (41)
Cash provided by continuing operating activities 457 408 793
Cash utilized in discontinued operating activities   (3) (2)
Total cash provided by operating activities 457 405 791
Investing activities:      
Cash payments for property, plant and equipment (311) (426) (536)
Acquisitions, net of cash acquired   (190) (123)
Contributions and advances to joint ventures   (22) (52)
Net cash proceeds on disposal of assets 10 197 11
Net cash proceeds on sale of ANZ businesses, net of transaction costs 441    
Deconsolidation of Paddock (47)    
Other,net   4 2
Cash provided by (utilized in) investing activities 93 (437) (698)
Financing activities:      
Additions to long-term debt 1,845 4,265 2,511
Repayments of long-term debt (2,460) (4,099) (2,353)
Increase (decrease) in short-term loans (15) 49 (18)
Payment of finance fees (51) (85) (13)
Dividends paid (8) (31)  
Net cash proceeds for hedging activity (8) 28  
Distributions paid to noncontrolling interests (12) (17) (22)
Treasury shares repurchased   (38) (163)
Sale leaseback proceeds in conjunction with ANZ sale 155    
Issuance of common stock and other (3) (4) 5
Cash provided by (utilized in) financing activities (557) 68 (53)
Effect of exchange rate fluctuations on cash 19 3 (20)
Increase in cash 12 39 20
Cash and cash equivalents at beginning of period 551 512 492
Cash and cash equivalents at end of period $ 563 $ 551 $ 512